LCAM Coalition expands global lung cancer awareness push for November

The Lung Cancer Awareness Movement Coalition is launching a worldwide awareness campaign during Lung Cancer Awareness Month, combining paid digital outreach in the U.S., U.K. and Spain with local partner events in November. The effort aims to widen access to information on early detection, treatment and support as lung cancer advances still fail to reach many people.

Why it matters: - Lung cancer remains one of the most urgent cancers to detect earlier and treat faster. - The LCAM Coalition is trying to move awareness closer to local communities, where people are more likely to act on screening, treatment and support information. - The 2026 campaign also spotlights the access gap: medical advances only help if people can actually reach them.

What happened: - The Lung Cancer Awareness Movement (LCAM) Coalition launched its 2026 Lung Cancer Awareness Month campaign on November 10, 2026. - The campaign combines targeted digital and social media outreach with local activation by Coalition members around the world. - The effort is led by GO2 for Lung Cancer, which stewards the LCAM Coalition.

The details: - Paid digital outreach will focus on the United States, the United Kingdom and Spain. - Coalition members will receive ready-to-use digital resources, social media content and other tools to amplify the campaign in their own countries and communities. - The campaign builds on the Coalition’s global partner network, allowing organizations to share messages through existing channels and relationships. - For the second straight year, Coalition members are expanding Shine a Light on Lung Cancer®, which is now in its 17th year, with local events throughout November. - Last year, more than 250 locations worldwide took part in Shine a Light. - Those events brought communities together to honor people affected by lung cancer, share information and encourage action. - The Coalition said the campaign is designed to make lung cancer more visible and help more people access information about early detection, treatment, research and support. - The LCAM Coalition thanked 2026 sponsors Boehringer Ingelheim, Johnson & Johnson, Lilly, Merck and Revolution Medicines. - More information is available at LCAM.org.

Between the lines: - David Benson, CEO of GO2 for Lung Cancer, said advances in low-dose CT screening, targeted therapies and immunotherapy are changing outcomes. - Benson also said too many people still do not know those advances exist. - The campaign’s structure shows a two-track strategy: broad paid media for reach, and local partner outreach for trust and relevance. - The emphasis on access suggests the coalition sees awareness as only part of the problem, with care availability still limiting progress.

What's next: - Coalition members will continue running local awareness efforts throughout November. - The digital campaign will keep running across Lung Cancer Awareness Month. - The LCAM Coalition is likely to keep using its global network to push early detection and treatment messages beyond major media markets. - The partner events and digital outreach are intended to reinforce one another as the month continues.

The bottom line: - The LCAM Coalition is using a global, localized campaign to turn lung cancer awareness into action, not just visibility.